Medicaid Formulary Decisions: Shift To MCOs May Limit Pharma Input – Study
Drug firms may find it harder to contribute to Medicaid formulary decisions in the coming years as state programs increasingly turn to managed care organizations to handle their pharmacy benefits, according to a recent research report by Avalere Health and the Kaiser Commission on Medicaid and the Uninsured.
You may also be interested in...
Prescription drug coverage under New York Medicaid will be shifted to its managed care program, effective Oct. 1, under the fiscal 2011-2012 budget approved by the state legislature.
Policymakers should instead focus on increasing efficiencies in drug development, distribution and reimbursement, National Academies report says, while also seeking broad policies like HHS direct negotiation for drug prices in Medicare.
Senate Finance confirmation hearing concluded without a vote on Xavier Becerra’s nomination as Health and Human Services Department secretary. Republicans continued to express concerns with his background and views. But he is expected to win enough votes to clear the committee.